Apple's Jobs reassures investors about his health

Tue Jan 6, 2009 1:02am GMT
 
Email | Print | | Single Page
[-] Text [+]

By Sinead Carew

NEW YORK (Reuters) - Apple Inc (AAPL.O) Chief Executive Steve Jobs sought to soothe investor concerns about his health on Monday, saying his weight loss was caused by a hormone imbalance that is relatively simple to treat.

Shares of Apple rose more than 5 percent in midday trade, as Jobs, a pancreatic cancer survivor, said he would remain CEO during his recovery and that his doctors expect him to regain his weight by late spring.

"I will be the first one to step up and tell our Board of Directors if I can no longer continue to fulfil my duties as Apple's CEO," Jobs said in a statement, breaking his silence about his health for the first time in months.

The statement followed widespread investor concern about the executive's health, after Jobs decided not to give the keynote speech at Apple product showcase Macworld this week. Speculation about his health resurfaced in June 2008, when Jobs appeared markedly thinner at an Apple event.

Jobs is seen as the driver of Apple's successful products, including Macintosh computers, iPod media players and iPhones.

He acknowledged he had been losing weight throughout 2008 and that his doctors determined "a hormone imbalance that has been 'robbing' me of the proteins my body needs to be healthy."

He said the remedy for "this nutritional problem is relatively simple and straightforward" and that he has begun treatment.

Investors who had been unnerved by Jobs's gaunt appearance last year, and the lack of a clear explanation from the company, heaved a sigh of relief.  Continued...

 
Zhu Zhu pet
Can I have one for Christmas?

The hottest toy in the U.S. this Christmas is an interactive hamster. It does not come from one of the major toy brands or from a movie but a small, seven-year-old company from Missouri.  Full Coverage 

Photo

Market Update

  • UKUK
  • USUS
  • Europe
  • Asia
  • UK Most Actives

Most Popular Business News on Reuters UK

  • Articles
  • Videos